prednisone has been researched along with Premature Birth in 12 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
Excerpt | Relevance | Reference |
---|---|---|
"Hydroxychloroquine (HCQ) is often needed to manage disease activity in systemic lupus erythematosus (SLE) during pregnancy." | 9.12 | Hydroxychloroquine in lupus pregnancy. ( Clowse, ME; Magder, L; Petri, M; Witter, F, 2006) |
" Prednisone, as an immune-regulatory agent, is widely used to improve the probability of implantation and pregnancy, although the evidence for efficacy is inadequate." | 5.69 | Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization: A Randomized Clinical Trial. ( Chen, ZJ; Cui, L; Dong, X; Du, X; Du, Y; Guan, Y; Hao, G; He, Y; Hong, Y; Huang, D; Huang, Y; Ji, X; Liu, J; Liu, JY; Lu, J; Lu, Y; Ni, T; Qi, J; Sun, Y; Tan, J; Vankelecom, H; Wang, J; Wei, D; Xu, B; Yan, J; Zhang, B; Zhang, H; Zhang, J; Zhang, Q; Zhao, S, 2023) |
" The HCQ group showed a trend towards lower dosage of prednisone (OR 0." | 5.46 | Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. ( de Hair, MJH; Derksen, RHWM; Fritsch-Stork, RDE; Kroese, SJ; Lely, AT; Limper, M; van Laar, JM, 2017) |
"Hydroxychloroquine (HCQ) is often needed to manage disease activity in systemic lupus erythematosus (SLE) during pregnancy." | 5.12 | Hydroxychloroquine in lupus pregnancy. ( Clowse, ME; Magder, L; Petri, M; Witter, F, 2006) |
"A prednisone-treated systemic flare occurred during the first trimester without later complication." | 2.50 | Adult-onset Still's disease and pregnancy: about ten cases and review of the literature. ( Broussolle, C; Durieu, I; Gerfaud-Valentin, M; Hot, A; Huissoud, C; Seve, P, 2014) |
"028) and prednisone dosage during pregnancy ≥12." | 1.72 | Good pregnancy outcomes in lupus nephritis patients with complete renal remission. ( Chen, D; Chen, Y; Hu, W; Li, K; Liu, Z; Yang, L; Zhang, H, 2022) |
" The HCQ group showed a trend towards lower dosage of prednisone (OR 0." | 1.46 | Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births. ( de Hair, MJH; Derksen, RHWM; Fritsch-Stork, RDE; Kroese, SJ; Lely, AT; Limper, M; van Laar, JM, 2017) |
"Pemphigus vulgaris is rare in pregnancy and active PV presents potential threats of fetal spread and transient lesion production, which is associated with increased mortality and morbidity in the fetus." | 1.40 | Pemphigus vulgaris in pregnancy. ( Gero, MJ; Ragsdale, BD; Salzberg, KW, 2014) |
"Twelve women (12%) experienced 13 miscarriages after a median of 50 months (range, 13-120) from the end of therapy." | 1.38 | Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. ( Alfò, M; Annechini, G; Cavalieri, E; De Sanctis, V; Enrici, RM; Filippone, FR; Minniti, G; Muni, R; Osti, MF; Pulsoni, A; Valeriani, M, 2012) |
"Preterm birth was more frequent in study group than general population (21." | 1.38 | Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility. ( Ahn, H; Beaman, K; Gilman-Sachs, A; Han, AR; Kwak-Kim, J; Park, JC; Vu, P, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y | 1 |
Li, K | 1 |
Zhang, H | 2 |
Liu, Z | 1 |
Chen, D | 1 |
Yang, L | 1 |
Hu, W | 1 |
Tao, S | 1 |
Du, J | 1 |
Chi, X | 1 |
Zhu, Y | 1 |
Wang, X | 1 |
Meng, Q | 1 |
Ling, X | 1 |
Diao, F | 1 |
Song, C | 1 |
Jiang, Y | 1 |
Lv, H | 1 |
Lu, Q | 1 |
Qin, R | 1 |
Huang, L | 1 |
Xu, X | 1 |
Liu, C | 1 |
Ding, Y | 1 |
Jiang, T | 1 |
Ma, H | 1 |
Xia, Y | 1 |
Liu, J | 2 |
Lin, Y | 1 |
Jin, G | 1 |
Hu, Z | 1 |
Sun, Y | 1 |
Cui, L | 1 |
Lu, Y | 1 |
Tan, J | 1 |
Dong, X | 1 |
Ni, T | 1 |
Yan, J | 1 |
Guan, Y | 1 |
Hao, G | 1 |
Liu, JY | 1 |
Zhang, B | 1 |
Wei, D | 1 |
Hong, Y | 1 |
He, Y | 1 |
Qi, J | 1 |
Xu, B | 1 |
Lu, J | 1 |
Zhang, Q | 1 |
Zhao, S | 1 |
Ji, X | 1 |
Du, X | 1 |
Zhang, J | 1 |
Wang, J | 1 |
Huang, Y | 1 |
Huang, D | 1 |
Du, Y | 1 |
Vankelecom, H | 1 |
Chen, ZJ | 1 |
Kroese, SJ | 1 |
de Hair, MJH | 1 |
Limper, M | 1 |
Lely, AT | 1 |
van Laar, JM | 1 |
Derksen, RHWM | 1 |
Fritsch-Stork, RDE | 1 |
Gerfaud-Valentin, M | 1 |
Hot, A | 1 |
Huissoud, C | 1 |
Durieu, I | 1 |
Broussolle, C | 1 |
Seve, P | 1 |
Salzberg, KW | 1 |
Gero, MJ | 1 |
Ragsdale, BD | 1 |
Leroux, M | 1 |
Desveaux, C | 1 |
Parcevaux, M | 1 |
Julliac, B | 1 |
Gouyon, JB | 1 |
Dallay, D | 1 |
Pellegrin, JL | 1 |
Boukerrou, M | 1 |
Blanco, P | 1 |
Lazaro, E | 1 |
De Sanctis, V | 1 |
Filippone, FR | 1 |
Alfò, M | 1 |
Muni, R | 1 |
Cavalieri, E | 1 |
Pulsoni, A | 1 |
Annechini, G | 1 |
Valeriani, M | 1 |
Osti, MF | 1 |
Minniti, G | 1 |
Enrici, RM | 1 |
Han, AR | 1 |
Ahn, H | 1 |
Vu, P | 1 |
Park, JC | 1 |
Gilman-Sachs, A | 1 |
Beaman, K | 1 |
Kwak-Kim, J | 1 |
Langen, ES | 1 |
Chakravarty, EF | 1 |
Liaquat, M | 1 |
El-Sayed, YY | 1 |
Druzin, ML | 1 |
Clowse, ME | 1 |
Magder, L | 1 |
Witter, F | 1 |
Petri, M | 1 |
Cavallasca, JA | 1 |
Laborde, HA | 1 |
Ruda-Vega, H | 1 |
Nasswetter, GG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Three-arm, Multicenter, Open-label Randomized Controlled Trial of Hydroxychloroquine and Low-dose Prednisone on Recurrent Spontaneous Abortion With Undifferentiated Connective Tissue Diseases: Protocol for the Immunosuppressant Regimens for Living FEtus[NCT03671174] | 420 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
Hydroxychloroquine Exposure in Systemic Lupus Erythematosus (SLE)[NCT03802188] | 3,700 participants (Anticipated) | Observational | 2018-05-09 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for prednisone and Premature Birth
Article | Year |
---|---|
Adult-onset Still's disease and pregnancy: about ten cases and review of the literature.
Topics: Adult; Cohort Studies; Disease Progression; Female; Glucocorticoids; Humans; Prednisone; Pregnancy; | 2014 |
2 trials available for prednisone and Premature Birth
Article | Year |
---|---|
Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization: A Randomized Clinical Trial.
Topics: Abortion, Habitual; Abortion, Spontaneous; Administration, Oral; Adult; Double-Blind Method; Embryo | 2023 |
Hydroxychloroquine in lupus pregnancy.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu | 2006 |
Hydroxychloroquine in lupus pregnancy.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu | 2006 |
Hydroxychloroquine in lupus pregnancy.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu | 2006 |
Hydroxychloroquine in lupus pregnancy.
Topics: Abortion, Spontaneous; Adult; Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroqu | 2006 |
9 other studies available for prednisone and Premature Birth
Article | Year |
---|---|
Good pregnancy outcomes in lupus nephritis patients with complete renal remission.
Topics: Adult; Female; Humans; Lupus Nephritis; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Ou | 2022 |
Associations between antenatal corticosteroid exposure and neurodevelopment in infants.
Topics: Adrenal Cortex Hormones; Cohort Studies; Dexamethasone; Female; Humans; Infant; Infant, Newborn; Inf | 2022 |
Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births.
Topics: Adult; Antibodies, Antiphospholipid; Antirheumatic Agents; Female; Humans; Hydroxychloroquine; Infan | 2017 |
Pemphigus vulgaris in pregnancy.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Dose-Response Relationship, Drug; Female; Fluorescent Antib | 2014 |
Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.
Topics: Adult; Antirheumatic Agents; Cohort Studies; Female; Fetal Growth Retardation; Gestational Age; Gluc | 2015 |
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital | 2012 |
Obstetrical outcome of anti-inflammatory and anticoagulation therapy in women with recurrent pregnancy loss or unexplained infertility.
Topics: Abortion, Habitual; Anti-Inflammatory Agents; Anticoagulants; Aspirin; Diabetes, Gestational; Female | 2012 |
High rate of preterm birth in pregnancies complicated by rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Congenital Abnormalities; Female; Fetal Distress | 2014 |
Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE).
Topics: Adult; Antiphospholipid Syndrome; Argentina; Comorbidity; Female; Humans; Infant, Low Birth Weight; | 2008 |